European Commission to support better diagnosis of rare diseases
This article was originally published in Clinica
Executive Summary
The European Commission adopted yesterday two documents to improve European action in the field of rare diseases. The aim of the Communication and proposal for a Council Recommendation on rare diseases is to set out an EU-wide strategy to support member states in diagnosing, treating and caring for the 36 million EU citizens with rare diseases.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.